<DOC>
	<DOCNO>NCT01956097</DOCNO>
	<brief_summary>The objective current study evaluate efficacy safety HX106 healthy adult subjective memory complaint improve neurocognitive function find change brain use magnetic resonance imaging association neurocognitive function enhancement .</brief_summary>
	<brief_title>Effects HX106 Improvement Cognitive-Bio-Markers Memory Function</brief_title>
	<detailed_description />
	<criteria>Age 20 60 year old , Global Deterioration Scale score ( GDS ) 2 One symptom subjective memory impairment High school high level education . Current pregnancy breastfeed Evidence neurologic medical condition Axis I diagnosis assess board certify psychiatrist use Structured Clinical Interview Diagnostic Statistical Manual Mental Disorder , 4th edition ( DSMIV ) ( SCIDIV ) , One major depressive episode last 12 month Minimental status examination score 24 less Clinical Dementia Rating score 0.5 suggest cognitive impairment beyond selfperceived subjective deficit Intelligence quotient le 80 Any history head trauma involve loss consciousness seizure Contraindications magnetic resonance imaging ( MRI ) Use psychotropics last 3 month Use oral contraceptive medication Participation clinical trial study period might affect outcome present study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>